Literature DB >> 7891822

Gene expression in Alzheimer neocortex as a function of age and pathologic severity.

C A Robinson1, A W Clark, I M Parhad, T S Fung, S S Bou.   

Abstract

Previous studies have shown a marked decline in neuronal and an increase in glial gene expression in Alzheimer's disease (AD) neocortex. Severity of pathologic changes may be greater in presenile AD (PAD) than in senile AD (SAD). We evaluated whether changes in transcript expression were altered as a function of age or pathologic severity. Northern analysis revealed a marked (> 50%) decline in expression of transcripts for the neurofilament light subunit and the major amyloid precursor protein (APP) isoforms in both PAD and SAD. Expression of these neuronal transcripts declined as a function of age in AD and control cases. Expression of the glial fibrillary acidic protein (GFAP) transcript was increased in AD, particularly in the presenile group. AD cases with larger numbers of neurofibrillary tangles had higher levels of GFAP transcript; AD cases with larger numbers of senile plaques had higher levels of APP695 transcript. We conclude that the neuronal mRNA decrements of AD are superimposed on an age-related decline. Age-related shift in expression of certain genes may account for the differences in pathologic severity of PAD and SAD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7891822     DOI: 10.1016/0197-4580(94)90049-3

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

1.  Novel antioxidants protect mitochondria from the effects of oligomeric amyloid beta and contribute to the maintenance of epigenome function.

Authors:  Diego Mastroeni; Omar M Khdour; Pablo M Arce; Sidney M Hecht; Paul D Coleman
Journal:  ACS Chem Neurosci       Date:  2015-02-24       Impact factor: 4.418

2.  Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice.

Authors:  Remi Dosunmu; Jinfang Wu; Lina Adwan; Bryan Maloney; Md Riyaz Basha; Christopher A McPherson; G Jean Harry; Deborah C Rice; Nasser H Zawia; Debomoy K Lahiri
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

3.  Age-related atrophy of motor axons in mice deficient in the mid-sized neurofilament subunit.

Authors:  G A Elder; V L Friedrich; A Margita; R A Lazzarini
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

4.  Expression profiles of multiple genes in single neurons of Alzheimer's disease.

Authors:  N Chow; C Cox; L M Callahan; J M Weimer; L Guo; P D Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

5.  Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology.

Authors:  Winnie S Liang; Travis Dunckley; Thomas G Beach; Andrew Grover; Diego Mastroeni; Keri Ramsey; Richard J Caselli; Walter A Kukull; Daniel McKeel; John C Morris; Christine M Hulette; Donald Schmechel; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Neurobiol Aging       Date:  2008-06-24       Impact factor: 4.673

6.  Epigenetic changes in Alzheimer's disease: decrements in DNA methylation.

Authors:  Diego Mastroeni; Andrew Grover; Elaine Delvaux; Charisse Whiteside; Paul D Coleman; Joseph Rogers
Journal:  Neurobiol Aging       Date:  2008-12-30       Impact factor: 4.673

7.  Gene Expression of Quaking in Sporadic Alzheimer's Disease Patients is Both Upregulated and Related to Expression Levels of Genes Involved in Amyloid Plaque and Neurofibrillary Tangle Formation.

Authors:  Bryn Farnsworth; Christiane Peuckert; Bettina Zimmermann; Elena Jazin; Petronella Kettunen; Lina Sors Emilsson
Journal:  J Alzheimers Dis       Date:  2016-05-06       Impact factor: 4.472

8.  A Novel Based-Network Strategy to Identify Phytochemicals from Radix Salviae Miltiorrhizae (Danshen) for Treating Alzheimer's Disease.

Authors:  Bo Li; Yu-Rui Wu; Lan Li; Yu Liu; Zhu-Yun Yan
Journal:  Molecules       Date:  2022-07-12       Impact factor: 4.927

Review 9.  Blood neurofilament light: a critical review of its application to neurologic disease.

Authors:  Christian Barro; Tanuja Chitnis; Howard L Weiner
Journal:  Ann Clin Transl Neurol       Date:  2020-11-04       Impact factor: 5.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.